您的购物车当前为空
SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes.
SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes.

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 26,600 | 3-6月 | |
| 50 mg | ¥ 33,800 | 3-6月 | |
| 100 mg | ¥ 42,500 | 3-6月 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
凭借在化合物合成方面的丰富经验,我们可以根据您的研究需求为该产品提供快速定制合成服务。
| 产品描述 | SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes. |
| 靶点活性 | SGLT1/ SGLT2 (human):29nM/20 nM |
| 分子量 | 669.85 |
| 分子式 | C37H55N3O8 |
| CAS No. | 1240305-17-2 |
| Smiles | O(C)C1=C(C=C(CC2=CC=C(/C=C/C(C(NC(C(NCCN(C)C)=O)(C)C)=O)(C)C)C=C2)C(C(C)C)=C1)[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O |
| 密度 | 1.182 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多